Tollgate-based progression pathways of ALS patients.

Area of Science:

• Neurology
• Clinical Medicine
• Biostatistics

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
• Understanding ALS progression across different functional segments (limb, bulbar, respiratory) is crucial for patient care.
• Existing staging systems may not fully capture the nuanced progression pathways in ALS.

Purpose of the Study:

• To apply the tollgate-based ALS staging system (TASS) to track ALS progression in limb, speech, swallowing, and breathing.
• To analyze longitudinal data from ALS patients to derive disease-specific progression pathways.
• To estimate the probability of reaching critical clinical milestones (tollgates) over time.

Main Methods:

• Utilized a longitudinal dataset of 514 ALS patients' medical records, including free-text clinical notes.
• Derived tollgate-based progression pathways within a 1-year period from the initial clinic visit.
• Employed Kaplan-Meier analyses to determine the time-dependent probability of passing each tollgate for functional segments.

Main Results:

• At initial visits, most patients exhibited limb (93%), bulbar (77%), and breathing (60%) weakness.
• Milder progression (tollgate level < 2) was less common for arm (38%) and leg (46%) segments compared to others (>65%).
• Patient progression pathways (TASS) were non-uniform; initial impairment influenced future needs, such as bi-level positive airway pressure device use.

Conclusions:

• TASS provides a framework for individualized ALS progression prediction.
• Clinicians can use TASS to inform patients about their likelihood of developing critical disabilities.
• This enables better preparation for assistive device needs, including mobility and respiratory support.